Cartesian Therapeutics, Inc. (RNAC): Revenue
$2.80M
Year ended 2025-12-31
$1.48M
Trailing 12 months to 2026-06-30
-7.4%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.80M | -92.8% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $38.91M | +49.6% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $26.00M | n/a | 2025-03-13, From 2023-01-01 |
| No annual figure between 2017-12-31 and 2023-12-31. | |||
| 2017-12-31 | $207.0K | -97.4% | 2018-03-15, From 2017-01-01 |
| 2016-12-31 | $8.08M | +34.5% | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | $6.01M | +97.7% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $3.04M | n/a | 2017-03-28, From 2014-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $2.80M | -92.8% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $2.85M | +20.4% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $2.98M | +19.0% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $3.02M | +71.6% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $2.49M | -37.1% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $3.50M | +436.5% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $3.55M | -46.2% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $2.07M | +3.7% |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $2.04M | -67.3% |
Compare RNAC, UPB, XBIO, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗